BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 23786233)

  • 21. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
    Ceresini G; Corcione L; Michiara M; Sgargi P; Teresi G; Gilli A; Usberti E; Silini E; Ceda GP
    Cancer; 2012 Nov; 118(22):5473-80. PubMed ID: 22517468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
    Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic Distribution of Papillary Thyroid Carcinoma by Mapping in Coronal Sections of 125 Consecutive Thyroidectomy Specimens.
    Mai KT; Gulavita P; Lai C; Swift J; Levac J; Olberg B; Purgina B
    Int J Surg Pathol; 2014 Jun; 22(4):303-15. PubMed ID: 24050958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma.
    Wei S; Gao M; Zhao C; Pan Y; Li H; Li J; Li X
    Int J Clin Oncol; 2014 Oct; 19(5):800-4. PubMed ID: 24096868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillary thyroid carcinoma with anaplastic dedifferentiation in the lymph node metastasis - a rare form of presentation even for a tall cell variant.
    Barbu CG; Florin A; Neamţu MC; Avramescu ET; Terzea D; Miron A; Dănciulescu Miulescu R; Poiană C; Fica S
    Rom J Morphol Embryol; 2015; 56(2):527-31. PubMed ID: 26193223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
    Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
    J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens.
    Solomon A; Gupta PK; LiVolsi VA; Baloch ZW
    Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
    Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
    Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma.
    Michels JJ; Jacques M; Henry-Amar M; Bardet S
    Hum Pathol; 2007 Feb; 38(2):212-9. PubMed ID: 17097131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma.
    Fang H; Si Y; Wang C; Gong Q; Liu C; Wang S
    Pathol Res Pract; 2021 Aug; 224():153510. PubMed ID: 34329840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graves' disease and papillary thyroid carcinoma: case report and literature review of a single academic center.
    Arosemena MA; Cipriani NA; Dumitrescu AM
    BMC Endocr Disord; 2022 Aug; 22(1):199. PubMed ID: 35945543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
    Kwon H; Moon BI
    World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual presentation of Warthin variant of Papillary thyroid carcinoma with lymph nodal metastases in a patient of Graves' disease.
    Padma S; Sundaram PS; Arun BR
    J Cancer Res Ther; 2015; 11(3):652. PubMed ID: 26458632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
    Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
    World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
    Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
    Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
    Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
    Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: A case control study.
    Karatzas T; Charitoudis G; Vasileiadis D; Kapetanakis S; Vasileiadis I
    Int J Surg; 2015 Jun; 18():64-8. PubMed ID: 25900600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.